Legal Action

Published on October 22nd, 2018

0

Smilow Cancer Hospital Database

A TINA.org investigation revealed that numerous cancer centers in the U.S. are deceptively using patient testimonials in their marketing materials, that is, testimonials that promote anecdotal, atypical patient results without clearly and conspicuously disclosing what the generally expected results for a patient in a similar situation would be. Moreover, within this sampling of deceptive testimonials many also promote clinical trials (i.e., research endeavors with no guarantee of therapeutic benefit), as well as novel treatments, such as immunotherapy and/or experimental procedures, without clearly and conspicuously disclosing their limitations, risks and relative rarity.

Below is a sampling of TINA.org’s findings for Smilow Cancer Hospital.  If any of the testimonials attribute the patient’s success to a clinical trial, the entry appears in bold italics.

This center was notified of TINA.org’s findings on October 22nd, 2018.

To learn more about the statistics and criteria used in TINA.org’s investigation, as well as other information, click here.

Name Cancer Type Testimonial SEER 5-Year Survival Rate*
Bob C. Lung, Stage 4 Facebook 1 (link) 4.7%
Bob C. Lung, Stage 4 Facebook 2 (link) 4.7%
Bob C. Lung, Stage 4 Website 4.7%
Debbi Head and Neck, Stage 4 Website 39.1%
Gary Throat, Stage 4 Video (as seen on Youtube) 39.1%
Jean M. Pancreatic, Stage 3 Website 11.5%
Jody L. Acute Myeloid Leukemia (AML) Website 27.4%
Kaitlin E. Brain Website 33.2%
Linda Lung Website 18.6%
Marissa A. Liver, Stage 4 Website 2.4%
Mark Pancreatic Website 8.5%
Mark Pancreatic Facebook (link, audio) 8.5%
Mary L. Ovarian Website 47.4%
Maureen O. Lung, Stage 4 Facebook (link, audio) 4.7%
Maureen O. Lung, Stage 4 Website 4.7%
Peter E. Bladder, Stage 3 Website 34.9%
Robert Esophageal, Stage 3 Website 23.6%
Ryan Stomach, Stage 4 Video (as seen on Youtube) 5.2%
Tasha E. Acute Myeloid Leukemia (AML) Website 27.4%
Victor Lung, Stage 3 Website 29.7%

 

Print Friendly, PDF & Email

Tags:




Leave a Reply

Back to Top ↑